AstraZeneca has denied news reports that it’s involved in talks with U.S. authorities about an emergency use authorization for its COVID-19 vaccine candidate. The denial comes after recent news reports claiming the Trump administration is eyeing a plan to fast-track the vaccine candidate, AZD1222, before the Nov. 3 presidential election. “AstraZeneca has not discussed emergency…